Because urinary L-FABP is a predictive biomarker for the renal prognosis and incidence of cardiovascular diseases in patients with type 2 diabetes, the combination of measurements of uACR and urinary L-FABP is considered useful in the prevention of diabetic angiopathies [37–39]. Here, FABP1 is linked to diabetic peripheral angiopathy.